Malte Ritter

CRISPR/Cas9-mediated <i>ELANE</i> knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients

Masoud Nasri, Malte Ritter, Perihan Mir et al. · Haematologica · 2019 · 57 citations · Full text

LMO2 activation by deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesis

Tatsuya Morishima, Ann-Christin Krahl, Masoud Nasri et al. · Blood · 2019 · 43 citations · Full text

iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropenia

Benjamin Dannenmann, Maksim Klimiankou, Benedikt Oswald et al. · Cell stem cell · 2021 · 27 citations · Full text

Key Oncogene, Hematological Malignancy, Mixed-phenotype Acute Leukemia +10

CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia

Masoud Nasri, Malte Ritter, Perihan Mir et al. · Molecular Therapy · 2024 · 15 citations · Full text

A topological refactoring design strategy yields highly stable granulopoietic proteins

Julia Skokowa, Birte Hernandez Alvarez, M.P. Coles et al. · Nature Communications · 2022 · 14 citations · Full text